Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
about
Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.Probable linezolid-induced thrombocytopenia in a patient with vancomycin-resistant enterococci.High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.Treatment of prosthetic osteoarticular infections.Prosthetic joint infection: diagnosis and management.The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.Drug treatments for prosthetic joint infections in the era of multidrug resistance.Oral antibiotic therapy.Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.Good practice in antibiotic use: what about linezolid in a French university hospital?The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength.Treatment recommendations and strategies for the management of bone and joint infections
P2860
Q33394332-AA25E904-A808-4881-87BE-77D0D385E042Q33400991-82223211-0209-4CE6-BEFC-12959E1CA047Q33407349-7A846A77-F03D-4681-B79D-FF8381317010Q33412202-D7FB0767-A89D-4CFE-9A15-7B22279D6AF1Q34157657-7CC39D9D-1B9B-4D21-8238-D094AA22F2BBQ34503844-3283404C-7E45-420B-BA97-7F2929F110BDQ37413851-76D033A5-682D-4D6A-A624-C03544C6993BQ37853179-DDB6E0DB-AC11-4C0C-BD5D-75BC95F9AED4Q37929757-E0594BD7-E48C-4C11-85C3-5013A32ADA44Q38084726-C5C3D165-3B8C-4EA0-B359-A7FC1A389A06Q38241474-FBA5B804-EE63-4E55-A2E4-DEE8C8747A77Q38800556-6F972604-9F09-49F7-98DC-D3B0B9EB42E3Q42231206-19812631-CCA5-40C2-88A8-2733D113684BQ42706257-CF62CFAA-D389-4E78-AA2A-BB3DD9F6DC4AQ43490644-4A2AB249-9A7D-485B-8E10-7F580451F4ABQ44046705-CD110AA9-D158-478E-99A4-C87F8CE7C732Q58405400-463C1FD3-DE35-48A9-82AB-5D06F66C953B
P2860
Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Efficacy and safety of linezol ...... ns: a prospective case series.
@ast
Efficacy and safety of linezol ...... ns: a prospective case series.
@en
type
label
Efficacy and safety of linezol ...... ns: a prospective case series.
@ast
Efficacy and safety of linezol ...... ns: a prospective case series.
@en
prefLabel
Efficacy and safety of linezol ...... ns: a prospective case series.
@ast
Efficacy and safety of linezol ...... ns: a prospective case series.
@en
P1476
Efficacy and safety of linezol ...... ns: a prospective case series.
@en
P2093
Cindy W Hamilton
Nalini Rao
P304
P356
10.1016/J.DIAGMICROBIO.2007.04.006
P577
2007-06-15T00:00:00Z